SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Carole S. Scherling, Tracey Hall, Flora Berisha, Kristen Klepac, Anna Karydas, Giovanni Coppola, Joel H. Kramer, Gil Rabinovici, Michael Ahlijanian, Bruce L. Miller, William Seeley, Lea T. Grinberg, Howard Rosen, Jere Meredith, Adam L. Boxer, Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration, Annals of Neurology, 2014, 75, 1
  2. 2
    Zhen-Xin Zhang, Honglei Chen, Sheng-Di Chen, Ming Shao, Sheng-Gang Sun, Qiu-Min Qu, Bao-Rong Zhang, Yi-Ming Liu, Qun Xu, Xia Wan, Ling Li, Hong-Bo Wen, Xia Chen, Hai-Bo Chen, Zhen-Guo Liu, Jian Wang, Gang Wang, Chinese culture permeation in the treatment of Parkinson disease: a cross-sectional study in four regions of China, BMC Research Notes, 2014, 7, 1, 65

    CrossRef

  3. 3
    Raja Mehanna, Suzanne Moore, J. Gabriel Hou, Aliya I. Sarwar, Eugene C. Lai, Comparing clinical features of young onset, middle onset and late onset Parkinson's disease, Parkinsonism & Related Disorders, 2014,

    CrossRef

  4. 4
    Kyum-Yil Kwon, Minjik Kim, Seon-Min Lee, Sung Hoon Kang, Hye Mi Lee, Seong-Beom Koh, Is reduced arm and leg swing in Parkinson's disease associated with rigidity or bradykinesia?, Journal of the Neurological Sciences, 2014,

    CrossRef

  5. 5
    Zeyan Liew, Anthony Wang, Jeff Bronstein, Beate Ritz, Job Exposure Matrix (JEM)-Derived Estimates of Lifetime Occupational Pesticide Exposure and the Risk of Parkinson's Disease, Archives of Environmental & Occupational Health, 2014, 69, 4, 241

    CrossRef

  6. 6
    Valerie E. Kelly, Anne Shumway-Cook, The ability of people with Parkinson’s disease to modify dual-task performance in response to instructions during simple and complex walking tasks, Experimental Brain Research, 2014, 232, 1, 263

    CrossRef

  7. 7
    A. Wang, M. Cockburn, T. T. Ly, J. M. Bronstein, B. Ritz, The association between ambient exposure to organophosphates and Parkinson's disease risk, Occupational and Environmental Medicine, 2014, 71, 4, 275

    CrossRef

  8. 8
    Pei-Chen Lee, Shannon L. Rhodes, Janet S. Sinsheimer, Jeff Bronstein, Beate Ritz, Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure, Environment International, 2013, 56, 42

    CrossRef

  9. 9
    S. Narayan, Z. Liew, K. Paul, P.-C. Lee, J. S. Sinsheimer, J. M. Bronstein, B. Ritz, Household organophosphorus pesticide use and Parkinson's disease, International Journal of Epidemiology, 2013, 42, 5, 1476

    CrossRef

  10. You have free access to this content10
    N. H. Rod, Y. Bordelon, A. Thompson, E. Marcotte, B. Ritz, Major life events and development of major depression in Parkinson's disease patients, European Journal of Neurology, 2013, 20, 4
  11. 11
    Nico Bunzeck, Victoria Singh-Curry, Cindy Eckart, Nikolaus Weiskopf, Richard J. Perry, Peter G. Bain, Emrah Düzel, Masud Husain, Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 12, 1136

    CrossRef

  12. 12
    Valerie E. Kelly, Alexis J. Eusterbrock, Anne Shumway-Cook, A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  13. 13
    Ignacio F. Mata, Harvey Checkoway, Carolyn M. Hutter, Ali Samii, John W. Roberts, Hojoong M. Kim, Pinky Agarwal, Victoria Alvarez, Renee Ribacoba, Pau Pastor, Oswaldo Lorenzo-Betancor, Jon Infante, María Sierra, Pilar Gómez-Garre, Pablo Mir, Beate Ritz, Shannon L. Rhodes, Amy Colcher, Vivianna Van Deerlin, Kathryn A. Chung, Joseph F. Quinn, Dora Yearout, Erica Martinez, Federico M. Farin, Jia Y. Wan, Karen L. Edwards, Cyrus P. Zabetian, Common variation in the LRRK2 gene is a risk factor for Parkinson's disease, Movement Disorders, 2012, 27, 14
  14. 14
    Stefanie D. Vassar, Yvette M. Bordelon, Ron D. Hays, Natalie Diaz, Rebecca Rausch, Cherry Mao, Barbara G. Vickrey, Confirmatory Factor Analysis of the Motor Unified Parkinson’s Disease Rating Scale, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  15. 15
    Julie Nantel, Jamie Currie McDonald, Helen Bronte-Stewart, Effect of medication and STN-DBS on postural control in subjects with Parkinson’s disease, Parkinsonism & Related Disorders, 2012, 18, 3, 285

    CrossRef

  16. 16
    L. Jin, J. Wang, H. Jin, G. Fei, Y. Zhang, W. Chen, L. Zhao, N. Zhao, X. Sun, M. Zeng, C. Zhong, Nigral iron deposition occurs across motor phenotypes of Parkinson’s disease, European Journal of Neurology, 2012, 19, 7
  17. 17
    Wang Zhan, Gail A. Kang, Graham A. Glass, Yu Zhang, Cheryl Shirley, Rachel Millin, Katherine L. Possin, Marzieh Nezamzadeh, Michael W. Weiner, William J. Marks, Norbert Schuff, Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging, Movement Disorders, 2012, 27, 1
  18. 18
    V. McGuire, S.K. Van Den Eeden, C.M. Tanner, F. Kamel, D.M. Umbach, K. Marder, R. Mayeux, B. Ritz, G.W. Ross, H. Petrovitch, B. Topol, R.A. Popat, S. Costello, A.D. Manthripragada, A. Southwick, R.M. Myers, L.M. Nelson, Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium, Journal of the Neurological Sciences, 2011, 307, 1-2, 22

    CrossRef

  19. 19
    R. A. Popat, S. K. Van Den Eeden, C. M. Tanner, F. Kamel, D. M. Umbach, K. Marder, R. Mayeux, B. Ritz, G. W. Ross, H. Petrovitch, B. Topol, V. McGuire, S. Costello, A. D. Manthripragada, A. Southwick, R. M. Myers, L. M. Nelson, Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s disease, European Journal of Neurology, 2011, 18, 5
  20. 20
    Dag Aarsland, Sven Påhlhagen, Clive G. Ballard, Uwe Ehrt, Per Svenningsson, Depression in Parkinson disease—epidemiology, mechanisms and management, Nature Reviews Neurology, 2011, 8, 1, 35

    CrossRef

  21. 21
    Valerie Voon, Mandy Sohr, Anthony E. Lang, Marc N. Potenza, Andrew D. Siderowf, Jacqueline Whetteckey, Daniel Weintraub, Glen R. Wunderlich, Mark Stacy, Impulse control disorders in parkinson disease: A multicenter case–control study, Annals of Neurology, 2011, 69, 6
  22. 22
    Yvette M. Bordelon, Ron D. Hays, Stefanie D. Vassar, Natalie Diaz, Jeff Bronstein, Barbara G. Vickrey, Medication Responsiveness of Motor Symptoms in a Population-Based Study of Parkinson Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  23. 23
    Anthony Wang, Sadie Costello, Myles Cockburn, Xinbo Zhang, Jeff Bronstein, Beate Ritz, Parkinson’s disease risk from ambient exposure to pesticides, European Journal of Epidemiology, 2011, 26, 7, 547

    CrossRef

  24. 24
    Shannon L. Rhodes, Janet S. Sinsheimer, Yvette Bordelon, Jeff M. Bronstein, Beate Ritz, Replication of GWAS Associations for GAK and MAPT in Parkinson's Disease, Annals of Human Genetics, 2011, 75, 2
  25. 25
    Krisztina K. Johansen, Linda R. White, Sigrid B. Sando, Jan O. Aasly, Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies, Parkinsonism & Related Disorders, 2010, 16, 5, 307

    CrossRef

  26. 26
    S. Costello, Y. Bordelon, J. Bronstein, B. Ritz, Familial associations of Alzheimer disease and essential tremor with Parkinson disease, European Journal of Neurology, 2010, 17, 6
  27. 27
    Andreas Plaitakis, Helen Latsoudis, Konstantinos Kanavouras, Beate Ritz, Jeff M Bronstein, Irene Skoula, Vasileios Mastorodemos, Spyridon Papapetropoulos, Nikolas Borompokas, Ioannis Zaganas, Georgia Xiromerisiou, George M Hadjigeorgiou, Cleanthe Spanaki, Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset, European Journal of Human Genetics, 2010, 18, 3, 336

    CrossRef

  28. 28
    Hidemoto Saiki, Takuya Hayashi, Ryosuke Takahashi, Jun Takahashi, Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease, Journal of Neuroscience Methods, 2010, 190, 2, 198

    CrossRef

  29. 29
    E.L. Jacob, N.M. Gatto, A. Thompson, Y. Bordelon, B. Ritz, Occurrence of depression and anxiety prior to Parkinson’s disease, Parkinsonism & Related Disorders, 2010, 16, 9, 576

    CrossRef

  30. 30
    Angelika D. Manthripragada, Sadie Costello, Myles G. Cockburn, Jeff M. Bronstein, Beate Ritz, Paraoxonase 1, Agricultural Organophosphate Exposure, and Parkinson Disease, Epidemiology, 2010, 21, 1, 87

    CrossRef

  31. 31
    Dag Aarsland, Martin Wilhelm Kurz, The epidemiology of dementia associated with Parkinson disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 18

    CrossRef

  32. 32
    F. R. Guerini, E. Beghi, G. Riboldazzi, R. Zangaglia, C. Pianezzola, G. Bono, C. Casali, C. Di Lorenzo, C. Agliardi, G. Nappi, M. Clerici, E. Martignoni, BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease, European Journal of Neurology, 2009, 16, 11
  33. 33
    Beate R. Ritz, Angelika D. Manthripragada, Sadie Costello, Sarah J. Lincoln, Matthew J. Farrer, Myles Cockburn, Jeff Bronstein, Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease, Environmental Health Perspectives, 2009, 117, 6, 964

    CrossRef

  34. 34
    S. Costello, M. Cockburn, J. Bronstein, X. Zhang, B. Ritz, Parkinson's Disease and Residential Exposure to Maneb and Paraquat From Agricultural Applications in the Central Valley of California, American Journal of Epidemiology, 2009, 169, 8, 919

    CrossRef

  35. 35
    Nicole M. Gatto, Myles Cockburn, Jeff Bronstein, Angelika D. Manthripragada, Beate Ritz, Well-Water Consumption and Parkinson’s Disease in Rural California, Environmental Health Perspectives, 2009, 117, 12, 1912

    CrossRef

  36. 36
    Jennifer S.A.M. Reijnders, Uwe Ehrt, Wim E.J. Weber, Dag Aarsland, Albert F.G. Leentjens, A systematic review of prevalence studies of depression in Parkinson's disease, Movement Disorders, 2008, 23, 2
  37. 37
    C. Tessa, M. Giannelli, R. Della Nave, C. Lucetti, C. Berti, A. Ginestroni, U. Bonuccelli, M. Mascalchi, A Whole-Brain Analysis in De Novo Parkinson Disease, American Journal of Neuroradiology, 2008, 29, 4, 674

    CrossRef

  38. 38
    Xuemei Huang, Robert D. Abbott, Helen Petrovitch, Richard B. Mailman, G. Webster Ross, Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study, Movement Disorders, 2008, 23, 7
  39. 39
    Mandy Miller Koop, Nicole Shivitz, Helen Brontë-Stewart, Quantitative measures of fine motor, limb, and postural bradykinesia in very early stage, untreated Parkinson's disease, Movement Disorders, 2008, 23, 9
  40. You have free access to this content40
    Murat Emre, Dag Aarsland, Richard Brown, David J. Burn, Charles Duyckaerts, Yoshikino Mizuno, Gerald Anthony Broe, Jeffrey Cummings, Dennis W. Dickson, Serge Gauthier, Jennifer Goldman, Christopher Goetz, Amos Korczyn, Andrew Lees, Richard Levy, Irene Litvan, Ian McKeith, Warren Olanow, Werner Poewe, Niall Quinn, Christina Sampaio, Eduardo Tolosa, Bruno Dubois, Clinical diagnostic criteria for dementia associated with Parkinson's disease, Movement Disorders, 2007, 22, 12